Cleerly LABS vs Eko Analysis Software
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your clinical workflow requires a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) to precisely quantify and characterize atherosclerosis and stenosis. This tool is ideal for detailed plaque assessment, personalized risk stratification, and tracking the progression of coronary artery disease over time.
View Cleerly LABS →Choose Eko Analysis Software if…
Choose Eko Analysis Software if you need an accessible, point-of-care AI-powered tool for the early detection of common cardiovascular conditions such as heart murmurs and atrial fibrillation during routine physical exams or remote monitoring. It is best suited for clinicians seeking to augment auscultation with AI assistance for initial screening and rapid assessment.
View Eko Analysis Software →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | Eko Analysis Software |
|---|---|---|
| Pricing | Varies | Freemium with subscription for full features |
| Deployment | Cloud, On-premise | Cloud-based |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Analysis SoftwareEko Analysis Software (Tool B) offers a more immediate and accessible point-of-care experience by integrating with digital stethoscopes and a mobile app. This allows for quick recordings and visualizations, making it highly usable for a broader range of clinicians in various settings. Cleerly LABS (Tool A), while web-based and integrated with hospital systems, targets a more specialized workflow.
Clinical Value
Cleerly LABSCleerly LABS (Tool A) provides comprehensive and quantitative analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, including tracking disease progression over time. This offers a deeper, more personalized understanding of coronary artery disease for long-term management. While Eko Analysis Software (Tool B) provides valuable early detection of heart murmurs and AFib, Cleerly's detailed plaque characterization and risk assessment offers a more profound clinical impact for complex CAD management.
Pricing & Value
Eko Analysis SoftwareEko Analysis Software (Tool B) offers a freemium model with a subscription for full AI-powered features, providing a lower entry cost and greater flexibility for individual clinicians or smaller practices. Cleerly LABS (Tool A) has a significantly higher per-analysis cost, often requiring out-of-pocket payment, which could be a barrier to widespread adoption despite its advanced capabilities.
Enterprise Readiness
Cleerly LABSCleerly LABS (Tool A) explicitly highlights integration with PACS, RIS, and EHR via a Cleerly Proxy, which is crucial for seamless workflow and data management within large healthcare enterprises. Both tools are cloud-based, HIPAA compliant, and FDA cleared, but Tool A's direct integration capabilities demonstrate a stronger focus on enterprise-level deployment and interoperability.
Innovation
Cleerly LABSCleerly LABS (Tool A) demonstrates significant innovation by leveraging AI for comprehensive CCTA analysis, including detailed plaque characterization and risk stratification, with the stated goal of creating a new standard of care to eliminate heart attacks. While Eko Analysis Software (Tool B) innovates by bringing AI-powered diagnostics to the point of care via digital stethoscopes, Cleerly's depth of analysis and potential to redefine CAD management offers a more transformative innovation in the field.
Support & Docs
TieBoth Cleerly and Eko appear to offer robust support and documentation for their users. Cleerly provides contact forms for general inquiries, software demos, and client support, along with educational resources. Eko offers an extensive support center with FAQs, user manuals, troubleshooting guides, and multiple contact options including phone, chat, and email, with specified response times for enterprise support. Without direct comparative reviews of their support quality, it is difficult to definitively choose a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | Eko Analysis Software |
|---|---|---|
| Tool Name | Cleerly LABS | Eko Analysis Software |
| Primary Function | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | FDA-cleared AI-powered tool that integrates with Eko's digital stethoscopes and mobile app to assist clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation. |
| Key AI Detections/Analysis | Comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with Cleerly ISCHEMIA module), 3D visualization of coronary arteries, personalized heart disease risk assessment, tracking disease progression over time. | Heart murmur detection, atrial fibrillation (AFib) detection, normal sinus rhythm detection, calculation of cardiac time intervals (heart rate, QRS duration). |
| Input Data Type | Coronary CT angiography (CCTA) images | Heart sounds and ECGs from digital stethoscopes |
| Specialties | Cardiology, Radiology | Cardiology, Emergency Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and Eko Analysis Software.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or Eko Analysis Software
Backers
Who funded each tool's parent company.